Abstract:Background Smoking is a major risk factor for chronic obstructive pulmonary disease (COPD) and also myocardial infarction (MI). Patients with COPD are more likely to have MI than those without and adequately treating COPD might improve cardiovascular outcomes. Reliable diagnosis is important for appropriate treatment. Prevalence of COPD in those hospitalised for MI has not been accurately established. Blood eosinophil count is an important guide to the benefit of inhaled corticosteroid (ICS) treatment in COPD. We aimed to accurately characterise lung function, symptom burden, eosinophil count and cardiopulmonary events in those with a significant smoking history hospitalised for acute MI. Methods Participants (n=216) with a smoking history of ≥10 pack-years currently hospitalised for acute MI were recruited at a single UK centre. Microspirometry and completion of the COPD Assessment Test (CAT) questionnaire were performed at enrolment. Presence and severity of COPD was graded using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification. A high burden of COPD symptoms was defined as a CAT score of >10. Repeat CAT and assessment for relevant cardiopulmonary events was undertaken at 3 months and 1 year after enrolment. Results In the enrolled cohort, median age was 60 years (IQR 53-67), 26% were female, 57% were current smokers and median pack-year history was 32 (23-45). 41 of 216 (19 %, [95% CI 14-25]) had evidence of COPD, defined as FEV1/FEV6 <0.7 on best-attempt microspirometry, with 39 (95%) being GOLD2 or greater. Of the 41 with detected COPD, only 15 (37%, [22-53]) had a prior diagnosis. In those with evidence of COPD, a high burden of COPD symptoms was present in 63% of participants at enrolment, 40% at 3 months and 45% at 1 year. 20% [9-35] were receiving inhaled corticosteroids at enrolment. 63% [47-78] had eosinophil count ≥100 cells/mm3 and 17% [7-32] ≥300 cells/mm3. Among those with detected COPD, after 1 year 19.5% (95% CI 9-35%) had suffered a respiratory illness requiring prescription of medication, which was numerically but not statistically significantly higher than those without detected COPD (14.3% [10-20%]). In the COPD cohort, death, infection requiring hospitalisation, MI or unplanned coronary revascularisation, and bleeding requiring hospitalisation each occurred on two occasions (4.9%). Conclusions Based on these data, the prevalence of microspirometry-diagnosed COPD of any severity in patients with significant smoking history hospitalised for MI is around 19%. There is a high rate of undiagnosed and untreated disease, a significant burden of symptoms, including during convalescence, and around a 20% incidence of respiratory illness requiring medical treatment at 1 year. Gathering accurate data from this group is helpful in planning research and service improvement. Increasing detection of COPD in patients with MI would lead to improved cardiopulmonary outcomes.

Clinical observation of chronic obstructive pulmonary disease with acute myocardial infarction

Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis

Clinical significance and changes of plasma brain natriuretic peptide level in patients with chronic obstructive pul monary disease under different conditions

Influence of chronic obstructive pulmonary disease on hospital outcomes of percutaneous coronary interventions in patients with acute coronary syndrome

The Prognostic Value of Cardiac Dysfunction Assessed by Bedside Echocardiography in Critically Ill Patients with COPD Requiring Mechanical Ventilation: a Study Protocol.

Clinical Study of Acute Myocardial Infarction with Normal Coronary Artery at Acute Phase Angiogram

The Correlation Factors Analyses of COPD Complicated by CI in Acute Exacerbation Time

Comorbidities and Short-Term Prognosis in Patients Admitted to the Intensive Care Unit for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

The Clinical and Coronary Artery Feature of Patients Diagnosised As Non-St-elevation Myocardial Infarction Accompanied with Acute Left Heart

Comparison of Point-of-care Testing and Laboratory Testing of Myocardial Damage Markers in the Diagnosis and Prognosis of Acute Coronary Syndrome

Comparative Study for Clinical Characteristics Between the Patients With TakoSTubo Cardiomyopathy and Acute Anterior ST-segment Elevation Myocardial Infarction

Diagnosis and therapy of acute myocardial infarction complicated with acute respiratory distresssyndrome

Detection of chronic obstructive pulmonary disease and frequency of cardiopulmonary events in patients with a significant smoking history hospitalised for acute myocardial infarction

Clinical Analysis of Elderly Acute Myocardial Infarction and Cardiogenic Shock after Coronary Intervention Treatment

Prevalence and Impact of Chronic Obstructive Pulmonary Disease in Ischemic Heart Disease: A Systematic Review and Meta-Analysis of 18 Million Patients

Risk factors and prognosis of cardiovascular disease in chronic obstructive pulmonary disease

Effects of COPD on Left Ventricular and Left Atrial Deformation in Patients with Acute Myocardial Infarction: Strain Analysis Using Speckle-Tracking Echocardiography

Observational Study of Chinese Medicine Syndrome Distribution in Patients with Acute Myocardial Infarction and Its Impact on Prognosis

Effects of Oxygen Therapy on Patients with Acute Myocardial Infarction during Emergency Percutaneous Coronary intervention

The Prognostic Analysis of Patients with Acute Myocardial Infarction Accompanied with Atrial Fibrillation

Retrospective Analysis of 118 Death Cases with Acute Myocardial Infarction